These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 940225)

  • 1. Relationship between pharmacological activity and blood level of a new anticholinergic agent, timepidium bromide (SA-504), in cats.
    Tamaki H; Meshi T
    Jpn J Pharmacol; 1976 Apr; 26(2):209-15. PubMed ID: 940225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal absorption of a new anticholinergic agent, timepidium bromide. II. Enhancement of absorption.
    Tamaki H; Meshi T
    Chem Pharm Bull (Tokyo); 1978 Feb; 26(2):387-93. PubMed ID: 639171
    [No Abstract]   [Full Text] [Related]  

  • 3. Intestinal absorption of a new anticholinergic agent, timepidium bromide. I. Various factors influencing absorption.
    Meshi T; Tamaki H
    Chem Pharm Bull (Tokyo); 1978 Feb; 26(2):379-86. PubMed ID: 25141
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic fate of timepidium bromide (SA-504)--Unstable metabolities in the rats.
    Sugihara J; Taga N
    Radioisotopes; 1977 Apr; 26(4):238-44. PubMed ID: 578322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of a new anticholinergic agent, 1, 1-dimethyl-5-methoxy-3-(dithien-2-ylmethylene) piperidinium bromide (SA-504).
    Tamaki H; Tanaka M; Murata S; Harigaya S; Kiyomoto A
    Jpn J Pharmacol; 1972 Oct; 22(5):685-99. PubMed ID: 4539786
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological actions of timepidium bromide on the motility of visceral smooth muscles and the secretion of digestive juice in experimental animals (author's transl)].
    Tamaki H; Saito K
    Nihon Yakurigaku Zasshi; 1978 Jul; 74(5):559-71. PubMed ID: 700518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of 1,1-dimethyl-5-methoxy-3-(dithien-2-ylmethylene)piperidinium bromide (SA-504). I. Biliary metabolites in rats.
    Meshi T; Nakamura S; Kanno T
    Chem Pharm Bull (Tokyo); 1973 Aug; 21(8):1709-19. PubMed ID: 4756818
    [No Abstract]   [Full Text] [Related]  

  • 8. [Direct action of timepidium bromide on the gastric mucosa and its inhibitory effect on pepsin secretion (author's transl)].
    Narikawa H; Oyama R; Harigaya S
    Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):71-8. PubMed ID: 6797904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a new anticholinergic agent (SA-504) on motility of the gastrointestinal tract and the urinary bladder in cats.
    Tamaki H; Ikeo T; Harigaya S; Nakajima H
    Jpn J Pharmacol; 1973 Jun; 23(3):391-400. PubMed ID: 4541952
    [No Abstract]   [Full Text] [Related]  

  • 10. [Absorption, distribution, excretion and metabolism of a basic ether compound (R97) with antispasmodic activity].
    Matsuda H; Kawaba T; Yamamoto Y; Ogawa S
    Nihon Yakurigaku Zasshi; 1976 Sep; 72(6):657-72. PubMed ID: 1034592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies of anesthesia adjuvants. I. Effect of SA-504 on circulatory dynamics].
    Mori Y; Kusumoto H; Tanimoto H; Kamegawa M; Nishimura N
    Masui; 1972 Apr; 21(4):336-40. PubMed ID: 5065378
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of timepidium bromide, an anticholinergic agent, on gastric and duodenal blood flow distribution in rabbits.
    Naito K; Otsuka M; Harigaya S
    Jpn J Pharmacol; 1982 Feb; 32(1):73-80. PubMed ID: 7087265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral effects of anticholinergic compounds.
    Albanus L
    Acta Pharmacol Toxicol (Copenh); 1970; 28(4):305-26. PubMed ID: 5536020
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene.
    Martin U; Römer D
    Arzneimittelforschung; 1978; 28(5):770-82. PubMed ID: 35171
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-hydroxy-3-piperidylidenemethane derivatives as spasmolytics.
    Kawazu M; Kanno T; Saito S; Tamaki H
    J Med Chem; 1972 Sep; 15(9):914-8. PubMed ID: 5051008
    [No Abstract]   [Full Text] [Related]  

  • 16. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one.
    Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G
    Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of timepidium bromide, hyoscine-N-butylbromide and atropine on the isolated guinea pig gallbladder and sphincter of Oddi.
    Takenaga H; Magaribuchi T; Nakajima H
    Jpn J Pharmacol; 1980 Jun; 30(3):317-23. PubMed ID: 7452982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereochemical studies of antimuscarinic agents. Diastereoisomeric esters of 3-tropanol, 1,3-dimethyl-4-piperidinol, and related compounds.
    Biggs DF; Casy AF; Jeffery WK
    J Med Chem; 1972 May; 15(5):506-9. PubMed ID: 5035272
    [No Abstract]   [Full Text] [Related]  

  • 19. [An efficacy study of a new antispasmodica, SA-504 upon the myogram and intraluminal pressure of the human colon (author's transl)].
    Takagi K; Takahashi T; Nagasaki A; Ishikawa M; Yamagata S
    Nihon Heikatsukin Gakkai Zasshi; 1973 Sep; 9(3):147-50. PubMed ID: 4807599
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological studies on basic ethers (R111 and R97) with antispasmodic activity].
    Matsuda H; Kato T; Yamamoto Y; Miichi H; Ogawa S
    Nihon Yakurigaku Zasshi; 1976 May; 72(4):381-95. PubMed ID: 987972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.